Alerts will be sent to your verified email
Verify Email
PREVEST
|
Prevest Denpro
|
Medicamen Biotech
|
Kilitch Drugs(India)
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
19.0 % | 6.92 % | 7.31 % |
|
5yr average Equity Multiplier
|
1.07 | 1.44 | 1.48 |
|
5yr Average Asset Turnover Ratio
|
0.6 | 0.55 | 0.56 |
|
5yr Avg Net Profit Margin
|
29.64 % | 8.69 % | 8.44 % |
|
Price to Book
|
4.63 | 1.92 | 2.25 |
|
P/E
|
27.26 | 49.51 | 21.67 |
|
5yr Avg Cash Conversion Cycle
|
42.6 Days | 49.75 Days | 14.76 Days |
|
Inventory Days
|
36.0 Days | 84.58 Days | 14.42 Days |
|
Days Receivable
|
44.41 Days | 139.4 Days | 136.16 Days |
|
Days Payable
|
39.32 Days | 264.75 Days | 212.73 Days |
|
5yr Average Interest Coverage Ratio
|
99.71 | 7.03 | 6.02 |
|
5yr Avg ROCE
|
25.39 % | 10.34 % | 11.26 % |
|
5yr Avg Operating Profit Margin
|
36.91 % | 15.51 % | 12.28 % |
|
5 yr average Debt to Equity
|
0.0 | 0.15 | 0.17 |
|
5yr CAGR Net Profit
|
2.94 % | -11.57 % | 48.72 % |
|
5yr Average Return on Assets
|
17.71 % | 4.73 % | 4.99 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.6 % | 40.46 % | 63.77 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -2.75 % | -4.48 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Prevest Denpro
|
Medicamen Biotech
|
Kilitch Drugs(India)
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|